SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA completes audit at Jubilant Pharmova’s step down subsidiary's facility

03 Aug 2022 Evaluate

United States Food and Drug Administration (USFDA) has concluded audit at Jubilant Pharmova’s step down subsidiary -- Jubilant Generics. The audit was conducted at Solid Dosage Formulations facility at Roorkee in Uttarakhand of Jubilant Generics. The USFDA has issued six observations pursuant to the completion of the audit. The company will submit an action plan on the observations and will engage with USFDA for next steps.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×